These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2177600)

  • 21. Antibodies to hepatitis C virus in Cuban blood donors.
    Rivero RA; Hedalgo-Gato R; Martinez M; Hernandez P; Ballester JM; Yamaguchi K; Fukuyoshi Y; Kiyokawa T; Takatsuki K
    Vox Sang; 1992; 63(4):285-6. PubMed ID: 1282758
    [No Abstract]   [Full Text] [Related]  

  • 22. [Practical approach to the discovery of a positive HCV serology in a blood donor].
    Elghouzzi MH; Giral P; Opolon P; Trepo C; Poupon R; Jullien AM
    Rev Fr Transfus Hemobiol; 1991 Jul; 34(4):315-42. PubMed ID: 1654911
    [No Abstract]   [Full Text] [Related]  

  • 23. Non-A, non-B hepatitis and the anti-HCV assay.
    Barbara JA; Contreras M
    Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [European Acute Transfusion Hepatitis Interferon Study (EATHIS)].
    Jullien AM; Dejean AM; Janot C; Trepo C
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):199-204. PubMed ID: 1329792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-HCV in post-transfusion hepatitis: deductions from a prospective study.
    Feinman SV; Berris B; Herst R
    J Hepatol; 1991 May; 12(3):377-81. PubMed ID: 1658122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-HCV antibodies among blood donors in Cantabria. Incidence and relation to transaminase levels].
    Pastor JM; Hermosa V; Ruiz Tagle MA; Zubizarreta A
    Sangre (Barc); 1990 Jun; 35(3):205-7. PubMed ID: 2118687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of hepatitis C virus infection in burn patients: detection of anti-C100, anti-C33c and anti-Core antibodies.
    Coursaget P; Lesage G; Simpson B; Mayelo V; Le Cann P
    Biomed Pharmacother; 1991; 45(10):445-9. PubMed ID: 1668142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-HCV and hemoglobinopathies].
    Mattlinger B; Couroucé AM; Girot R
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):369-73. PubMed ID: 2177601
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
    Takano S; Omata M; Ohto M; Nakamura K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.
    van der Poel CL; Reesink HW; Lelie PN; Leentvaar-Kuypers A; Choo QL; Kuo G; Houghton M
    Lancet; 1989 Aug; 2(8658):297-8. PubMed ID: 2569103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incidence of anti-HCV and ALT in blood donors].
    Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C
    Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels.
    Rumi MG; Colombo M; Gringeri A; Mannucci PM
    Ann Intern Med; 1990 Mar; 112(5):379-80. PubMed ID: 2106281
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to hepatitis C and surrogate markers in blood donors.
    Koerner K; Stampe D; Glück D; Kubanek B
    Vox Sang; 1991; 61(2):138-9. PubMed ID: 1662427
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interactions between chronic viral hepatitis C and pregnancy].
    Grangé JD; Abergel A; Amiot X; Chaslin-Ferbus D; Aygalenq P; Fouqueray B; Valla D; Bommelaer G; Bodin F
    Gastroenterol Clin Biol; 1995 May; 19(5):520-4. PubMed ID: 7590005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of primary- and re-infection with hepatitis C virus in blood transfusion recipients.
    Meng ZD; Xu DG; Sun DG; Lu HY; Copland J; Liu CY; Ma XK; Chen SF; Niu JZ; Sun YD
    J Gastroenterol Hepatol; 1994; 9(3):211-6. PubMed ID: 7519893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. A prospective study in Finland.
    Ebeling F
    Vox Sang; 1991; 60(4):219-24. PubMed ID: 1681620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [International status of anti-HCV screening and conclusions].
    Habibi B
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):379-82. PubMed ID: 2177603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.